Basit öğe kaydını göster

dc.contributor.authorOzoguz, Aslihan
dc.contributor.authorUyan, Ozgun
dc.contributor.authorBirdal, Gunes
dc.contributor.authorIskender, Ceren
dc.contributor.authorKartal, Ece
dc.contributor.authorLahut, Suna
dc.contributor.authorOmur, Ozgur
dc.contributor.authorAgim, Zeynep Sena
dc.contributor.authorEken, Asli Gundogdu
dc.contributor.authorSen, Nesli Ece
dc.contributor.authorKavak, Pinar
dc.contributor.authorSaygi, Ceren
dc.contributor.authorSapp, Peter C.
dc.contributor.authorKeagle, Pamela
dc.contributor.authorParman, Yesim
dc.contributor.authorTan, Ersin
dc.contributor.authorKoc, Filiz
dc.contributor.authorDeymeer, Feza
dc.contributor.authorOflazer, Piraye
dc.contributor.authorHanagasi, Hasmet
dc.contributor.authorGurvit, Hakan
dc.contributor.authorBilgic, Basar
dc.contributor.authorDurmus, Hacer
dc.contributor.authorErtas, Mustafa
dc.contributor.authorKotan, Dilcan
dc.contributor.authorAkalin, Mehmet Ali
dc.contributor.authorGulluoglu, Halil
dc.contributor.authorZarifoglu, Mehmet
dc.contributor.authorAysal, Fikret
dc.contributor.authorDosolu, Nilgun
dc.contributor.authorBilguvar, Kaya
dc.contributor.authorGunel, Murat
dc.contributor.authorKeskin, Ozlem
dc.contributor.authorAkgun, Tahsin
dc.contributor.authorOzcelik, Hilmi
dc.contributor.authorLanders, John E.
dc.contributor.authorBrown, Robert H.
dc.contributor.authorBasak, A. Nazli
dc.date.accessioned2019-12-10T11:26:10Z
dc.date.available2019-12-10T11:26:10Z
dc.date.issued2015
dc.identifier.issn0197-4580
dc.identifier.urihttps://doi.org/10.1016/j.neurobiolaging.2014.12.032
dc.identifier.urihttp://hdl.handle.net/11655/15747
dc.description.abstractThe frequency of amyotrophic lateral sclerosis (ALS) mutations has been extensively investigated in several populations; however, a systematic analysis in Turkish cases has not been reported so far. In this study, we screened 477 ALS patients for mutations, including 116 familial ALS patients from 82 families and 361 sporadic ALS (sALS) cases. Patients were genotyped for C9orf72 (18.3%), SOD1 (12.2%), FUS (5%), TARDBP (3.7%), and UBQLN2 (2.4%) gene mutations, which together account for approximately 40% of familial ALS in Turkey. No SOD1 mutations were detected in sALS patients; however, C9orf72 (3.1%) and UBQLN2 (0.6%) explained 3.7% of sALS in the population. Exome sequencing revealed mutations in OPTN, SPG11, DJ1, PLEKHG5, SYNE1, TRPM7, and SQSTM1 genes, many of them novel. The spectrum of mutations reflect both the distinct genetic background and the heterogeneous nature of the Turkish ALS population. (C) 2015 Elsevier Inc. All rights reserved.
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.isversionof10.1016/j.neurobiolaging.2014.12.032
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGeriatrics & Gerontology
dc.subjectNeurosciences & Neurology
dc.titleThe Distinct Genetic Pattern of ALS in Turkey and Novel Mutations
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalNeurobiology Of Aging
dc.contributor.departmentNöroloji
dc.identifier.volume36
dc.identifier.issue4
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster